Stem Cell-Like Dog Placenta Cells Afford Neuroprotection against Ischemic Stroke Model via Heat Shock Protein Upregulation

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Yu, SeongJin ^a   Tajiri, Naoki ^a   Franzese, Nick ^a   Franzblau, Max ^a   Bae, EunKyung ^a   Platt, Simon ^b   Kaneko, Yuji ^a   Borlongan, Cesar V ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; MICROTUBULE ASSOCIATED PROTEIN 2; NEURON SPECIFIC NUCLEAR PROTEIN;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CEREBROVASCULAR ACCIDENT; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DOG; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; MALE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PHENOTYPE; PLACENTA; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL TRANSPLANTATION; UPREGULATION;

ANIMALS; DOGS; FEMALE; HSP27 HEAT-SHOCK PROTEINS; IMMUNOHISTOCHEMISTRY; NEUROPROTECTIVE AGENTS; PLACENTA; PREGNANCY; RATS; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; STEM CELLS; STROKE; UP-REGULATION;

EID: 84884578185     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076329     Document Type: Article

References (56)

1. Gredal H, Toft N, Westrup U, Motta L, Gideon P, et al. (2013) Survival and clinical outcome of dogs with ischaemic stroke. Vet J 196: 408-413.
2. Onteniente B, (2013) The multiple aspects of stroke and stem cell therapy. Curr Mol Med 13: 821-831.
3. Wang L, Lin Z, Shao B, Zhuge Q, Jin K, (2013) Therapeutic applications of bone marrow-derived stem cells in ischemic stroke. Neurol Res 35: 470-478.
4. Meamar R, Dehghani L, Ghasemi M, Khorvash F, Shaygannejad V, (2013) Stem cell therapy in stroke: a review literature. Int J Prev Med 4: S139-146.
5. Rosado-de-Castro PH, Pimentel-Coelho PM, Barbosa da Fonseca LM, de Freitas GR, Mendez-Otero R (2013) The Rise of Cell Therapy Trials for Stroke: Review of Published and Registered Studies. Stem Cells Dev.
6. Revencu T, Trifan V, Nacu L, Gutium T, Globa L, et al. (2013) Collection, isolation and characterization of the stem cells of umbilical cord blood. Rom J Morphol Embryol 54: 291-297.
7. Heneidi S, Simerman AA, Keller E, Singh P, Li X, et al. (2013) Awakened by cellular stress: isolation and characterization of a novel population of pluripotent stem cells derived from human adipose tissue. PLoS One 8: e64752.
8. Raff M, (2003) Adult stem cell plasticity: fact or artifact? Annu Rev Cell Dev Biol 19: 1-22.
9. Barcena A, Muench MO, Kapidzic M, Fisher SJ, (2009) A new role for the human placenta as a hematopoietic site throughout gestation. Reprod Sci 16: 178-187.
10. Ilancheran S, Moodley Y, Manuelpillai U, (2009) Human fetal membranes: a source of stem cells for tissue regeneration and repair? Placenta 30: 2-10.
11. Barlow S, Brooke G, Chatterjee K, Price G, Pelekanos R, et al. (2008) Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev 17: 1095-1107.
12. Troyer DL, Weiss ML, (2008) Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26: 591-599.
13. Bailo M, Soncini M, Vertua E, Signoroni PB, Sanzone S, et al. (2004) Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 78: 1439-1448.
14. Parolini O, Alviano F, Bagnara GP, Bilic G, Buhring HJ, et al. (2008) Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26: 300-311.
15. Yen BL, Huang HI, Chien CC, Jui HY, Ko BS, et al. (2005) Isolation of multipotent cells from human term placenta. Stem Cells 23: 3-9.
16. Miki T, Lehmann T, Cai H, Stolz DB, Strom SC, (2005) Stem cell characteristics of amniotic epithelial cells. Stem Cells 23: 1549-1559.
17. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FH, et al. (2003) Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102: 1548-1549.
18. Romanov YA, Svintsitskaya VA, Smirnov VN, (2003) Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 21: 105-110.
19. Kholodenko IV, Yarygin KN, Gubsky LV, Konieva AA, Tairova RT, et al. (2012) Intravenous xenotransplantation of human placental mesenchymal stem cells to rats: comparative analysis of homing in rat brain in two models of experimental ischemic stroke. Bull Exp Biol Med 154: 118-123.
20. Chen J, Shehadah A, Pal A, Zacharek A, Cui X, et al. (2012) Neuroprotective Effect of Human Placenta-derived Cell Treatment of Stroke in Rats. Cell Transplant.
21. Yarygin KN, Kholodenko IV, Konieva AA, Burunova VV, Tairova RT, et al. (2009) Mechanisms of positive effects of transplantation of human placental mesenchymal stem cells on recovery of rats after experimental ischemic stroke. Bull Exp Biol Med 148: 862-868.
22. Borlongan CV, (2009) Cell therapy for stroke: remaining issues to address before embarking on clinical trials. Stroke 40: S146-148.
23. Kondziolka D, Steinberg GK, Wechsler L, Meltzer CC, Elder E, et al. (2005) Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg 103: 38-45.
24. Bliss TM, Andres RH, Steinberg GK, (2010) Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis 37: 275-283.
25. Stem Cell Therapies as an Emerging Paradigm in Stroke P (2009) Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke 40: 510-515.
26. Franklin TB, Krueger-Naug AM, Clarke DB, Arrigo AP, Currie RW, (2005) The role of heat shock proteins Hsp70 and Hsp27 in cellular protection of the central nervous system. Int J Hyperthermia 21: 379-392.
27. Reynolds LP, Allen GV, (2003) A review of heat shock protein induction following cerebellar injury. Cerebellum 2: 171-177.
28. Krueger-Naug AM, Hopkins DA, Armstrong JN, Plumier JC, Currie RW, (2000) Hyperthermic induction of the 27-kDa heat shock protein (Hsp27) in neuroglia and neurons of the rat central nervous system. J Comp Neurol 428: 495-510.
29. Lin B, Ginsberg MD, Busto R, Dietrich WD, (1998) Sequential analysis of subacute and chronic neuronal, astrocytic and microglial alterations after transient global ischemia in rats. Acta Neuropathol 95: 511-523.
30. Borlongan CV, Yamamoto M, Takei N, Kumazaki M, Ungsuparkorn C, et al. (2000) Glial cell survival is enhanced during melatonin-induced neuroprotection against cerebral ischemia. FASEB J 14: 1307-1317.
31. Brambilla R, Abbracchio MP, (2001) Modulation of cyclooxygenase-2 and brain reactive astrogliosis by purinergic P2 receptors. Ann N Y Acad Sci 939: 54-62.
32. Dawson DA, Hallenbeck JM, (1996) Acute focal ischemia-induced alterations in MAP2 immunostaining: description of temporal changes and utilization as a marker for volumetric assessment of acute brain injury. J Cereb Blood Flow Metab 16: 170-174.
33. Noto T, Furuichi Y, Ishiye M, Matsuoka N, Aramori I, et al. (2007) Tacrolimus (FK506) limits accumulation of granulocytes and platelets and protects against brain damage after transient focal cerebral ischemia in rat. Biol Pharm Bull 30: 313-317.
34. Popp A, Jaenisch N, Witte OW, Frahm C, (2009) Identification of ischemic regions in a rat model of stroke. PLoS One 4: e4764.
35. Imura T, Shimohama S, Sato M, Nishikawa H, Madono K, et al. (1999) Differential expression of small heat shock proteins in reactive astrocytes after focal ischemia: possible role of beta-adrenergic receptor. J Neurosci 19: 9768-9779.
36. Kato H, Kogure K, Liu XH, Araki T, Kato K, et al. (1995) Immunohistochemical localization of the low molecular weight stress protein HSP27 following focal cerebral ischemia in the rat. Brain Res 679: 1-7.
37. Stetler RA, Gao Y, Zhang L, Weng Z, Zhang F, et al. (2012) Phosphorylation of HSP27 by protein kinase D is essential for mediating neuroprotection against ischemic neuronal injury. J Neurosci 32: 2667-2682.
38. Shen CC, Lin CH, Yang YC, Chiao MT, Cheng WY, et al. (2010) Intravenous implanted neural stem cells migrate to injury site, reduce infarct volume, and improve behavior after cerebral ischemia. Curr Neurovasc Res 7: 167-179.
39. Liu SP, Ding DC, Wang HJ, Su CY, Lin SZ, et al. (2010) Nonsenescent Hsp27-upregulated MSCs implantation promotes neuroplasticity in stroke model. Cell Transplant 19: 1261-1279.
40. Borlongan CV, Tajima Y, Trojanowski JQ, Lee VM, Sanberg PR, (1998) Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Exp Neurol 149: 310-321.
41. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, et al. (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17: 472-476.
42. Sanberg PR, Borlongan CV, Othberg AI, Saporta S, Freeman TB, et al. (1997) Testis-derived Sertoli cells have a trophic effect on dopamine neurons and alleviate hemiparkinsonism in rats. Nat Med 3: 1129-1132.
43. Stetler RA, Cao G, Gao Y, Zhang F, Wang S, et al. (2008) Hsp27 protects against ischemic brain injury via attenuation of a novel stress-response cascade upstream of mitochondrial cell death signaling. J Neurosci 28: 13038-13055.
44. Teramoto S, Shimura H, Tanaka R, Shimada Y, Miyamoto N, et al. (2013) Human-derived physiological heat shock protein 27 complex protects brain after focal cerebral ischemia in mice. PLoS One 8: e66001.
45. An JJ, Lee YP, Kim SY, Lee SH, Lee MJ, et al. (2008) Transduced human PEP-1-heat shock protein 27 efficiently protects against brain ischemic insult. FEBS J 275: 1296-1308.
46. Murphy JM, Fink DJ, Hunziker EB, Barry FP, (2003) Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 48: 3464-3474.
47. Luyten FP, (2004) Mesenchymal stem cells in osteoarthritis. Curr Opin Rheumatol 16: 599-603.
48. Awad HA, Butler DL, Boivin GP, Smith FN, Malaviya P, et al. (1999) Autologous mesenchymal stem cell-mediated repair of tendon. Tissue Eng 5: 267-277.
49. El-Badri NS, Maheshwari A, Sanberg PR, (2004) Mesenchymal stem cells in autoimmune disease. Stem Cells Dev 13: 463-472.
50. Pluchino S, Martino G, (2005) The therapeutic use of stem cells for myelin repair in autoimmune demyelinating disorders. J Neurol Sci 233: 117-119.
51. Uccelli A, Zappia E, Benvenuto F, Frassoni F, Mancardi G, (2006) Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection. Expert Opin Biol Ther 6: 17-22.
52. Black LL, Gaynor J, Gahring D, Adams C, Aron D, et al. (2007) Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: a randomized, double-blinded, multicenter, controlled trial. Vet Ther 8: 272-284.
53. Black LL, Gaynor J, Adams C, Dhupa S, Sams AE, et al. (2008) Effect of intraarticular injection of autologous adipose-derived mesenchymal stem and regenerative cells on clinical signs of chronic osteoarthritis of the elbow joint in dogs. Vet Ther 9: 192-200.
54. Kranz A, Wagner DC, Kamprad M, Scholz M, Schmidt UR, et al. (2010) Transplantation of placenta-derived mesenchymal stromal cells upon experimental stroke in rats. Brain Res 1315: 128-136.
55. Thirumala S, Goebel WS, Woods EJ, (2013) Manufacturing and banking of mesenchymal stem cells. Expert Opin Biol Ther 13: 673-691.
56. Timmins NE, Kiel M, Gunther M, Heazlewood C, Doran MR, et al. (2012) Closed system isolation and scalable expansion of human placental mesenchymal stem cells. Biotechnol Bioeng 109: 1817-1826.